ArticleClinical diabetes : a publication of the American Diabetes Association2025
Improving Medication Adherence and Medication Optimization With a Medicaid-Funded Statewide Diabetes Quality Improvement Project.
Article in Clinical diabetes : a publication of the American Diabetes Association, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
14 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Medication adherence is a barrier to achieving glycemic goals among Medicaid recipients with diabetes. The Diabetes Quality Improvement Program Collaborative recruited 19 primary care practices serving a high volume of Medicaid patients in Ohio with the goal of reducing the percentage of adults with type 2 diabetes with A1C >9.0% through a 1-year intervention. The mean medication possession ratio (MPR) improved from 71.6% during the pre-intervention period to 74.1% at year 1 post-intervention-a relative improvement of 3.4%. Factors associated with a lower MPR included younger age, identifying as non-Hispanic Black or Hispanic, and a pre-intervention A1C >9.0%. Although the initiative modestly improved medication adherence, addressing persistent disparities and expanding prescribing of therapies with cardiorenal benefits will be necessary to improve diabetes outcomes in the Medicaid population.
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.